|

The herd immunity theory is in serious doubt

Study suggests widespread long-term herd immunity will be difficult to achieve.

Covid-19 Antibodies Waning Over Time

The herd immunity thesis claims that if enough people get Covid they will become immune to reinfection slowing the spread of the disease.

However, an Antibody Study Shows Immunity May Wear Off.

The survey of 365,000 adults in England who tested themselves at home using a finger-prick test showed the proportion of people testing positive for Covid-19 antibodies declined by 26.5% between June 20—12 weeks after the peak of infections in the country—and Sept. 28.

Doctors don’t yet know whether antibodies confer any effective immunity against reinfection by Covid-19. But even if they do and the results of this survey are confirmed, it suggests the prospect of widespread long-term herd immunity to the virus will be difficult to achieve. Herd immunity occurs when enough people in a population develop an immune response, either through previous infection or vaccination, so that the virus can’t spread easily and even those who aren’t immune have protection.

The authors admitted the trial had limitations. “It included nonoverlapping random samples of the population, but it is possible that people who had been exposed to the virus were less likely to take part over time, which may have contributed to apparent population antibody waning,” they said.

Blow to Herd Immunity Theory

A 26.5% reduction in antibodies in just 12 weeks is quite a significant reduction. 

If accurate, it calls into question expected results from vaccines as well. 

Whereas I stated "if accurate" and "calls into question" the Financial Times says Covid-19 herd immunity theory dealt blow by UK research.

Jonathan Ball, professor of molecular virology at Nottingham university, said that while the React-2 study “confirms suspicions” about waning immunity in elderly populations, it is less clear what the relationship is between declining immunity and susceptibility to reinfection.

False Promise of Herd Immunity 

Nature.Com discusses the false promise of herd immunity for COVID-19.

Proposals to largely let the virus run its course — embraced by Donald Trump’s administration and others — could bring “untold death and suffering”.

In early October, a libertarian think tank and a small group of scientists released a document called the Great Barrington Declaration. In it, they call for a return to normal life for people at lower risk of severe COVID-19, to allow SARS-CoV-2 to spread to a sufficient level to give herd immunity. People at high risk, such as elderly people, it says, could be protected through measures that are largely unspecified. The writers of the declaration received an audience in the White House, and sparked a counter memorandum from another group of scientists in The Lancet, which called the herd-immunity approach a “dangerous fallacy unsupported by scientific evidence”.

“Surrendering to the virus” is not a defensible plan, says Kristian Andersen, an immunologist at the Scripps Research Institute in La Jolla, California. 

“Attempting to reach herd immunity via targeted infections is simply ludicrous,” Andersen says. “In the US, probably one to two million people would die.”

Guessing Game

Clearly everyone is guessing. 

It's equally clear that herd immunity proponents are making potentially disastrous guesses.

The same applies to the notion that vaccines will be immediately successful.

But the worst guess goes to Donald Trump who stated on February 26, "The 15 (cases in the US) within a couple of days is going to be down to close to zero.

Author

Mike “Mish” Shedlock's

Mike “Mish” Shedlock's

Sitka Pacific Capital Management,Llc

More from Mike “Mish” Shedlock's
Share:

Editor's Picks

EUR/USD tests 1.1800 barrier above 50-day EMA

EUR/USD gains ground after three days of losses, trading around 1.1790 during the Asian hours on Thursday. The 14-day Relative Strength Index momentum indicator at 47 (neutral) reflects easing momentum. The RSI below 50 keeps momentum balanced and could limit follow-through.

GBP/USD struggles near four-week low vs. USD, below 1.3500 amid BoE rate cut bets

The GBP/USD pair is seen consolidating its weekly losses registered over the past three days and oscillating in a narrow range near a four-week trough, touched during the Asians session on Thursday. Spot prices currently trade just below the 1.3500 psychological mark and seem vulnerable to slide further.

Gold consolidates below $5,000 amid geopolitical risk, hawkish FOMC Minutes

Gold extends its sideways consolidative price move through the Asian session on Thursday and remains below the $5,000 psychological mark as traders seem hesitant amid mixed cues. The US Dollar preserves its strong gains to over a one-week high in the wake of somewhat hawkish Minutes of the US Federal Reserve’s January monetary policy meeting. 

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Mixed UK inflation data no gamechanger for the Bank of England

Food inflation plunged in January, but service sector price pressure is proving stickier. We continue to expect Bank of England rate cuts in March and June. The latest UK inflation read is a mixed bag for the Bank of England, but we doubt it drastically changes the odds of a March rate cut.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.